osilodrostat
osilodrostat is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Isturisa. Available dosage form: tablet, coated.
Drug Details
- Generic Name
- osilodrostat
- Brand Names
- Isturisa
- Application Number
- NDA212801
- Sponsor
- Recordati Rare Diseases, Inc.
- NDC Codes
- 1
- Dosage Forms
- TABLET, COATED
- Routes
- ORAL
- Active Ingredients
- OSILODROSTAT PHOSPHATE
Indications and Usage
1 INDICATIONS AND USAGE ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative. ISTURISA is a cortisol synthesis inhibitor indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative ( 1 )